NCT05317845View on ClinicalTrials.gov

An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa

CompletedOBSERVATIONAL
Enrollment

4,089

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

No treatment given

The clinical management and prescribed treatment of diabetes and eASCVD/ASCVD risk factors are independent of this study and are part of the routine clinical practice at the discretion of the treating physician.

Trial Locations (7)

Unknown

Novo Nordisk Investigational Site, Manama

Novo Nordisk Investigational Site, Alexandria

Novo Nordisk Investigational Site, Amman

Novo Nordisk Investigational Site, As Sālimīyah

Novo Nordisk Investigational Site, Doha

Novo Nordisk Investigational Site, Johannesburg

Novo Nordisk Investigational Site, Abu Dhabi

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05317845 - An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa | Biotech Hunter | Biotech Hunter